Guy Debruyne active positions
Companies | Position | Start | End |
---|---|---|---|
Blue Star Invest SA | Chief Executive Officer | - | - |
CG Cube SA | Director/Board Member | - | - |
Le Bocholtz SA | Director/Board Member | - | - |
Mithra Pharmaceuticals CDMO SA
Mithra Pharmaceuticals CDMO SA Pharmaceuticals: MajorHealth Technology Part of Mithra Pharmaceuticals SA, Mithra Pharmaceuticals CDMO SA is a Belgian biotech company that focuses on transforming women's health through innovation. The company is based in Liege, Belgium and has a global presence in over 100 countries with a staff count of approximately 300. Mithra CDMO is an integrated research, development, and manufacturing platform that takes products from proof of concept to market. The company's current research and development pipeline includes two products based on the novel natural estrogen, estetrol (e4), as well as three complex therapeutics. The company was founded in 2013, and the CEO is François Fornieri. | Director/Board Member | - | - |
Career history of Guy Debruyne
Former positions of Guy Debruyne
Companies | Position | Start | End |
---|---|---|---|
MITHRA PHARMACEUTICALS S.A. | Director/Board Member | 14/07/2011 | - |
Statistics
International
Belgium | 4 |
Luxembourg | 3 |
Operational
Director/Board Member | 4 |
Chief Executive Officer | 1 |
Sectoral
Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
MITHRA PHARMACEUTICALS S.A. | Health Technology |
Private companies | 4 |
---|---|
Blue Star Invest SA | |
CG Cube SA | |
Le Bocholtz SA | |
Mithra Pharmaceuticals CDMO SA
Mithra Pharmaceuticals CDMO SA Pharmaceuticals: MajorHealth Technology Part of Mithra Pharmaceuticals SA, Mithra Pharmaceuticals CDMO SA is a Belgian biotech company that focuses on transforming women's health through innovation. The company is based in Liege, Belgium and has a global presence in over 100 countries with a staff count of approximately 300. Mithra CDMO is an integrated research, development, and manufacturing platform that takes products from proof of concept to market. The company's current research and development pipeline includes two products based on the novel natural estrogen, estetrol (e4), as well as three complex therapeutics. The company was founded in 2013, and the CEO is François Fornieri. | Health Technology |
- Stock Market
- Insiders
- Guy Debruyne
- Experience